Market Research Logo

Fierce 15 in Oncology Drug Pipeline Update

Fierce 15 in Oncology Drug Pipeline Update

The prestigious Fierce 15 biotech award has come to symbolize novelty and being at the forefront of biotechnology development amongst privately held businesses. The winners of this award are aiming at breakthroughs and big things, not at being 'me-too'.
This unique product, the 'Fierce 15 in Oncology Drug Pipeline Update' gathers the last six years (2010-2015) of Fierce 15 awards and identifies that no less than 54 of these biotech companies who are developing cancer drugs. This is a solid 60% of all companies given the award.
Fierce 15 companies are fast movers and to date no less than seventeen out of the 54 companies are public companies and four have been acquired, namely Amira Pharmaceuticals, Aragon Pharmaceuticals, Avila Therapeutics and Plexxikon.
FibroGen is the oldest among them, founded in 1993, otherwise all others are from the beginning of 2000 to present day. Among the very latest of the start-ups you will find Surface Oncology, Intellia Therapeutics, CRISPR Therapeutics, SQZ Biotech and Unum Therapeutics.
Available for the first time, Fierce 15 in Oncology lets you perform detailed pipeline analysis on their collective and very impressive pipeline of more than 290 drugs, spanning from Discovery to Marketed and in-house to co-development/in-licensing. Twenty eight drugs have one or more orphan drug designations and six drugs have received breakthrough therapy designation. Key technologies among this group of companies include CAR-T, TCRs, Immuno-oncology, Immune checkpoints, Gene editing etc.
There are today 72 companies plus partners developing 201 Fierce 15 drugs in 600 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 34 drugs. Fierce 15 In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 130 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 121 out of the 124 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 39 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.

How May Drug Pipeline Update Be of Use?
* Show investors/board/management that you are right on top of drug development progress in your therapeutic area. * Find competitors, collaborations partners, M&A candidates etc. * Jump start competitive drug intelligence operations * Excellent starting point for world wide benchmarking * Compare portfolio and therapy focus with your peers * Speed up pro-active in-/out licensing strategy work * Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug. Drug Pipeline Update is delivered to you as a downloadable application, which requires no installation on your computer. Please read more about application features and system requirements below.

Drug Pipeline Update at a Glance

Investigators
Includes more than 72 principal companies plus their collaborators. There is direct access from inside the application to web pages of all principal companies.

Note: You are able to sort and find drugs according to companies and partners from drop-down menus in the application. You may also sort and find drugs according to country of companies.

Drug name & Synonyms
Lists commercial, generic and code names for drugs.

Developmental stage
This Drug Pipeline Update contains 201 Fierce 15 drugs in development, which have a total of 600 developmental projects in cancer. In addition there are suspended and ceased drugs.

Pipeline Breakdown According to Number of Drugs
Marketed# 4
Pre-registration# 1
Phase III# 9
Phase II# 39
Phase I# 60
Preclinical# 91
No Data# 3
Suspended# 2
Ceased# 34

Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application.

Indications
Included Fierce 15 drugs are also in development for 129 other indications, where of 102 are different cancer indications.

Note: You are able to find and sort drugs according to type of indication from drop-down menu in the application.

Targets
Mutations
All targets are cross-referenced with the Catalogue of Somatic Mutations in Cancer (COSMIC). It is designed to store and display somatic mutation information and related details and contains information relating to human cancers. To date 121 out of the 124 studied drug targets so far have been recorded with somatic mutations and the software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information.

Biological Structures
The identity of available biological structures on 95 drug targets was retrieved from the RCSB Protein Databank for you to easily review the 1407 structures available today among drug targets.

Identified drugs are linked to more than 130 different targets, divided into 39 classifications of molecular function:
Antigen binding
ATPase activity
Auxiliary transport protein activity
Catalytic activity
Cell adhesion molecule activity
Cytokine activity

DNA binding
DNA topoisomerase activity
Extracellular matrix structural constituent
G-protein coupled receptor activity
Growth factor activity
GTPase activity
Helicase activity
Kinase activity
Ligand-dependent nuclear receptor activity
Ligase activity
Lipid kinase activity
Metallopeptidase activity
Methyltransferase activity
MHC class I receptor activity
Molecular function unknown
Protein binding
Protein serine/threonine kinase activity
Protein-tyrosine kinase activity
Receptor activity
Receptor binding
Receptor signaling complex scaffold activity
Receptor signaling protein serine/threonine kinase activity
Structural constituent of cytoskeleton
Sugar-phosphatase activity
T cell receptor binding
Transcription factor activity
Transcription regulator activity
Transferase activity
Translation regulator activity
Transmembrane receptor activity
Transmembrane receptor protein tyrosine kinase activity
Transporter activity
Ubiquitin-specific protease activity

Sub-Cellular Localization
Identified targets are categorized into 21 different primary and alternate sub-cellular localizations:
Basolateral membrane
Cell junction
Cell surface
Centrosome
Clathrin-coated vesicle
Cytoplasm
Cytoskeleton
Endoplasmic reticulum
Endosome
Extracellular
Extracellular matrix
Golgi apparatus
Integral to membrane
Kinetochore
Mitochondrion
Nucleolus
Nucleus
Perinuclear region
Plasma membrane
Ribosome
Secreted

Note: You are able to find and sort drugs according to target gene name, protein name, molecular function of target, target localization, presence of mutations and availability of biological structures of target from drop-down menus in the application.

Target Expression Profile
Direct links are provided from inside the application to 187 protein expression profiles of 115 drug targets in various human tissues and cancer types, cell lines and primary cells, including up to:
48 different normal tissue types
20 different types of cancer
47 cell lines
12 samples of primary blood cells

Pathway Referals
Identified targets have been cross referenced against their involvement in different cellular pathways, according to BioCarta, KEGG, NCI-Nature and NetPath.
BioCarta# 179 Pathways
KEGG# 152 Pathways
NCI-Nature# 200 Pathways
NetPath# 32 Pathways

Note: You are able to find and sort drugs according to targeted pathways from drop-down menus in the application.

Mechanism
In total there are different drug mechanism of action represented in this Drug Pipeline Update.

Note: You are able to find and sort drugs according to mechanism of action from drop-down menu in the application.

Compound
Identified drug compounds are described by:

Compound type, Chemical name, CAS Number and molecular weight

Note: You are able to sort and find drugs according to compound type from drop-down menu in the application.

Drug Profile
Progress analysis and review of drug development. A typical drug profile reports on, depending on stage of development and available information:

Drug Name & Synonyms
Presentation of drug name and synonyms

Principal Company & Partners
Presentation of principal company and partners

Target and Molecular Function of Target
Described target(s) is/are presented with:
Official Gene Symbol – Chromosome Location – Gene & Protein Name – Molecular Function

Target Localization
Described target(s) is/are presented with primary and alternate localizations.
Target Expression Profiles
Links to protein expression profile(s) of target(s) in various human tissues, cell lines and primary cells, including up to:
48 different normal tissue types
20 different types of cancer
47 cell lines
12 samples of primary blood cells

Mutation
All targets are cross-referenced with the Catalogue of Somatic Mutations in Cancer (COSMIC). It is designed to store and display somatic mutation information and related details and contains information relating to human cancers.

Biological Structures
The identity of available biological structures on drug targets was retrieved from the RCSB Protein Databank for you to easily review what available structures of drug targets exist.

Targeted Pathways
Described target(s) is/are matched for the involvement in cellular pathways according to BioCarta, KEGG, NCI-Nature and NetPath.

Mechanism
Drug mechanism of action

Developmental Projects
Summary field of developmental projects for the drug, including indication, developmental stage and status.
Example:
Cancer, myeloma – Phase II Clinical Trial – Active
Cancer, prostate – Phase III Clinical Trial – Ceased

Drug Description
Short introduction to drug

Compound Data
Compound type, Chemical name, CAS Number and molecular weight

Patent Data
Available patent information related to the drug is presented here.

Fillings and Approvals
Approvals and submissions
Analyst comments

Deals & Licensing
Collaborations and deals
Availability for licensing

Phase IV Data
Available Phase IV development data, developmental history and scientific data.

Phase III Data
Available Phase III development data, developmental history and scientific data.

Phase II Data
Available Phase II development data, developmental history and scientific data.

Phase I Data
Available Phase I development data, developmental history and scientific data.

Phase 0 Data
Available Phase 0 development data, developmental history and scientific data.

Preclinical Data
Available preclinical development data, developmental history and scientific data.

Discovery Data
Available discovery development data, developmental history and scientific data.

Application Features
Search, Find and Filter Panel with Initial Result Presentation
With this panel you can define your selectivity in each drug search with up to 24 different drug specific parameters. Each parameter has multi-select options to them and can be used as either an inclusion parameter or exclusion parameter.


The initial result table is a dynamic sortable table which gives you a fast overview of found results and can be narrowed down further by your own additional keywords.

Direct linkage from inside the application to related internet resources
Drug data is linked to search engines like Google and PubMed
Drug target data is linked directly to BioCarta, Human Protein Atlas, KEGG, NCI-Nature, NetPath etc.
Direct links to company web pages of companies

Dynamic Report Generator
Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser (Internet Explorer and FireFox), whether it is a single drug profile or an entire search you want have a report of.




System Requirements
Operating system: Windows (2000/XP/Vista/7/8) for Mac Users the service is only available online
Browser Application (Internet Explorer, Firefox, Chrome, Safari)
Internet access (to access related internet resources)


Please Note: For TOC please view description

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report